Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 87 (3) , 201-204
- https://doi.org/10.1016/s1081-1206(10)62226-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivityPublished by Elsevier ,2000
- Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity?Annals of Internal Medicine, 2000
- 806 Lack of cross-reactivity between selective COX-2 inhibitors and aspirin (ASA) in ASA, sensitive asthmatic subjectsJournal of Allergy and Clinical Immunology, 2000
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999
- The Use of Nimesulide in Patients with Acetylsalicylic Acid and Nonsteroidal Anti-Inflammatory Drug IntoleranceJournal of Asthma, 1999
- Relative safety of meloxicam in NSAID‐intolerant patientsAllergy, 1998
- Oral Challenge with Alternative Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Paracetamol in Patients Intolerant to these AgentsDrugs, 1993
- Efficacy and Tolerability of Nimesulide in Asthmatic Patients Intolerant to AspirinDrugs, 1993
- Aspirin and allergic diseases: A reviewThe American Journal of Medicine, 1983